Skip to content

Impact of Palliative Catheter Placement on the Quality of Life of Patients With Refractory Ascites

Impact of Palliative Catheter Placement on the Quality of Life of Patients With Refractory Ascites

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01188746
Enrollment
50
Registered
2010-08-25
Start date
2010-08-31
Completion date
2020-02-29
Last updated
2020-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ascites

Keywords

catheter, palliative, quality of life, 10-059

Brief summary

The purpose of this study is look at how treatments for ascites affect quality of life. Your quality of life is the ability for you to enjoy the normal things you do. Ascites (pronounced as-ī-tees) is the presence of extra fluid in the abdomen. Sometimes ascites is caused by cancer, also called malignancy. All people who participate in this study have ascites associated with cancer. Ascites can cause symptoms that make it difficult for the patient to do simple things. Patients with ascites often report: Abdominal swelling Difficulty walking. Difficulty breathing. Feeling full when eating. Clothes not fitting due to a swollen abdomen. Swelling in the legs. It is hoped that this catheter will relieve the symptoms of the ascites. The goal of the investigators study is to understand the quality of life before the procedure and after the procedure. Since the patient is having this procedure to make their symptoms better, the investigators want to hear from the patient of how the procedure has affected their quality of life.

Interventions

BEHAVIORALMcGill Quality of Life Questionnaire and the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire

Participants will be interviewed twice (if they chose to participate in the qualitative portion) and complete instruments at three time points: 1) immediately prior to the procedure, 2)within seven days after the procedure, preferably prior to discharge, and 3) three weeks after their catheter placement.

Sponsors

Memorial Sloan Kettering Cancer Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with a stage IV malignancy or end-stage disease documented in patient's chart. * Patients referred to interventional radiology for treatment of refractory ascites with the placement of a permanent catheter including, but not limited to, a Tenckhoff catheter, a PleurX catheter, or a Denver Shunt. * Fluency in English to enable instrument and interview completion. * Patients must be at least 18 years of age. * Patients must be physically capable of completing instruments and/or interview. * Patients must be able to comprehend and execute informed consent.

Exclusion criteria

* Unable to complete questionnaire due to a significant physical or mental deficits as assessed by the consenting professional. * Proxy completion is not accepted * Medical or psychiatric condition that, in the judgment of the investigator, prevents appropriate comprehension and execution of either the informed consent or the study instrument

Design outcomes

Primary

MeasureTime frameDescription
Determine if there is change in the QoL2 yearsof patients who have refractory ascites after the placement of a palliative catheter in Interventional Radiology.
Determine if there is change in symptoms2 yearsof patients who have refractory ascites after the placement of a palliative catheter in Interventional Radiology.

Secondary

MeasureTime frameDescription
Determine the impact ascites has on quality of life2 yearsvia patient interviews and how this is affected by catheter placement.
Monitor and describe post-catheter placement morbidity and mortality.2 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026